# Study Comparing Glycerin With 1% Lidocaine and Epinephrine Versus Glycerin With 1% Lidocaine Without Epinephrine for the Sclerotherapy of Leg Telangiectasias

> **NCT07342413** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Goldman, Butterwick, Fitzpatrick and Groff** · enrollment: 20 (estimated)

## Conditions studied

- Leg Veins

## Interventions

- **DRUG:** Right leg treated with Glycerin compounded with 1% Lidocaine and Epinephrine
- **DRUG:** Left leg treated with Glycerin compounded with 1% Lidocaine and Epinephrine

## Key facts

- **NCT ID:** NCT07342413
- **Lead sponsor:** Goldman, Butterwick, Fitzpatrick and Groff
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-01
- **Primary completion:** 2026-05-30
- **Final completion:** 2026-07-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07342413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07342413, "Study Comparing Glycerin With 1% Lidocaine and Epinephrine Versus Glycerin With 1% Lidocaine Without Epinephrine for the Sclerotherapy of Leg Telangiectasias". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT07342413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*